COVID-19 Vaccines Appear Safe During Pregnancy: Early Data

Scientists at the US CDC report no red flags in a preliminary analysis of the safety of Pfizer/BioNTech’s and Moderna’s mRNA-based immunizations among expectant mothers.

Written byChristie Wilcox, PhD
| 2 min read
pregnancy pregnant covid-19 coronavirus pandemic sars-cov-2 vaccine immunization moderna mrna pfizer/biontech

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, MARINA DEMIDIUK

Although transmission of the SARS-CoV-2 across the placenta is rare, pregnant people are at an increased risk for severe COVID-19, which is why many experts and scientific societies have argued that vaccination is a must during pregnancy. However, initial clinical trials excluded pregnant people, so there has been limited clinical data on this population.

Now, the first large-scale results are in, and they are encouraging. According to a study by scientists at the US Centers for Disease Control and Prevention published in the New England Journal of Medicine yesterday (April 21), there are no increased risks of severe side effects or adverse pregnancy outcomes from either the Moderna or Pfizer/BioNTech COVID-19 vaccines currently authorized for emergency use in the US.

The study examined self-reported symptoms from more than 35,000 people aged 16 to 54 who were pregnant when they received their COVID-19 vaccination and who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies